Meeting the Experts. Scientific Program



Friday 27th September 2019


  • 09:30 - 10:00

    Welcome

    Rafael Bernabeu. Instituto Bernabeu. Alicante, Spain.

  • Session I: New Markers of Ovarian Response

    Chairman: Joaquín Llácer. Instituto Bernabeu. Alicante, Spain.
    Chairman: Christine Wyns. Cliniques Universitaires Saint-Luc. Brussels, Belgium.


  • 10:00 - 10:20

    Future markers of Ovarian Reserve

    Luca Persani. University Milan. Milan, Italy.

  • 10:20 - 10:40

    Ovarian Sensitivity as a marker in IVF

    Carlo Alviggi. University of Naples Federico II. Naples, Italy.

  • 10:40 - 10:55

    Debate



    Session II: What's the Ideal Stimulation?

    Chairman: Michael Scholtes. Düsseldorf IVF Center of the VivaNeo Group. Germany
    Chairman: Athanasios Papathanasiou. BournHall Fertility Clinic. Cambridge, UK.

  • 10:55 - 11:15

    Mild Stimulation is alive and very well

    Geeta Nargund. Create Fertility. London, UK.

  • 11:15 - 11:45

    Maximal Stimulation is the best Strategy for the Majority of our patients

    Michael Alper. Boston IVF. Boston, EEUU.

  • 11:45 - 12:00

    Debate



  • 12:00 - 12:30

    Coffee break



    Session III: Individualization. Is it Worth it?

    Chairman: Rehan Salim. IVF Hammersmith Clinic. Wolfson Fertility Centre. London, UK.
    Chairman: Ruth Romero. Instituto Bernabeu. Alicante, Spain.

  • 12:30 - 12:50

    "One size fits all"

    Ben Willem Mol. Monash University / Monash Medical Center. Victoria, Australia.

  • 12:50 - 13:10

    Ovarian Stimulation in the era of precision medicine

    Christophe Blockeel. Centre for Reproduction Medicine at Brussels University Hospital. Brussels, Belgium.

  • 13:10 - 13:25

    Debate



  • 13:25 - 15:00

    Lunch break



    Session IV: The Trigger and the "Freeze all Strategy"

    Chairman: Shahar Kol. IVF Unit Elisha Hospital. Haifa, Israel.
    Chairman: Liv Bente. Spiren Fertilitetsklinikk. Trondheim, Norway.

  • 15:00 - 15:20

    Agonist trigger not only to avoid OHSS

    Juan Carlos Castillo. Instituto Bernabeu. Alicante, Spain.

  • 15:20 - 15:40

    Is fresh transfer still the first choice for patients?

    Ben Willem Mol. Monash University / Monash Medical Center. Victoria, Australia.

  • 15:40 - 15:55

    Debate



    Session V. Endometrial receptivity Assessment (clinical markers)

    Chairman: Belén Moliner. Instituto Bernabeu. Alicante, Spain.
    Chairman: Isidoro Bruna. HM Fertility Center. HM Universitary Group. Madrid, Spain.

  • 15:55 - 16:15

    Progesterone as a marker of endometrial receptivity

    Peter Humaidan. The Fertility Clinic Skive Regional Hospital. Skive, Denmark.

  • 16:15 - 16:35

    Ultrasound markers of endometrial receptivity. Uterine Contractility

    Kannamannadiar Jayaprakasan. Royal Derby Hospital and University. Nottingham, UK.

  • 16:35 - 16:50

    Debate



    Session VI. Endometrial receptivity Assessment (the molecular biology perspective)

    Chairman: David Keefe. New York University, Langone Medical Center. New York, USA.
    Chairman: Laura de la Fuente. 12 de Octubre Hospital. Madrid, Spain.

  • 16:50 - 17:10

    The role of Microbiome in fertility disorders

    Andrea Bernabeu. Instituto Bernabeu. Alicante, Spain.

  • 17:10 - 17:30

    Looking for a transcriptomic profile of refractory endometrium

    José Horcajadas. Pablo de Olavide University. Sevilla, Spain.

  • 17:30 - 17:45

    Debate



  • 17:45 - 18:15

    Coffee break



  • 18:15 - 18:35

    Special Lecture. What are we really doing? Impact of ART in Human Epigenetics

    Pilar Coy. Murcia University. Murcia, Spain.


Saturday, 28th September, 2019


  • Session I: Time to pregnancy

    Chairman: Jorge Ten. Instituto Bernabeu. Alicante, Spain.
    Chairman: Michael Dooley. The Poundbury Clinic. Dorchester, UK.

  • 09:30 - 09:50

    Strategies shortening the time to live (the point of view of the gynecologist).

    Rafael Bernabeu. Instituto Bernabeu. Alicante, Spain.

  • 09:50 - 10:10

    Strategies shortening the time to live (the point of view of the embryologist).

    Etienne Van den Abbeel. University Hospital Ghent. Ghent, Belgium.

  • 10:10 - 10:25

    Debate



  • Session II: PGT as a tool in the management of IVF patients

    Chairman: José Antonio Ortiz. Instituto Bernabeu. Alicante, Spain.
    Chairman: Juan José Espinós. Assisted Reproduction Center. Sagrada Familia Clinic. Barcelona, Spain.

  • 10:25 - 10:45

    PGT evidence based medicine and update on PGT-A.

    Santiago Munné. Overture Life / Yale University. New York, EEUU.

  • 10:45 - 11:05

    Is time to moving forward to Non-invasive PGT-A.

    Sijia Lu. Yikon Genomics. Shanghai, China.

  • 11:05 - 11:20

    Debate



  • 11:20 - 11:50

    Coffee break



    Session III: Looking inside the Embryo

    Chairman: Meen Yau Thum. Lister Hospital. Chelsea, UK.
    Chairman: Francisco J. Iborra. Centro Nacional de Biotecnología (CSIC). Madrid, Spain.

  • 11:50 - 12:10

    Mitochondria and embryo competence.

    Belén Lledó. Instituto Bernabeu. Alicante, Spain.

  • 12:10 - 12:30

    Artificial intelligence of Embryo selection.

    Diego Ezcurra. MERCK/EMD Serono. Boston, EEUU.

  • 12:30 - 13:00

    Special Lecture. Artificial intelligence: Big data in Human Reproduction.

    Nuria Oliver. Data-Pop Alliance / Vodafone Institute. Alicante, Spain.

  • 13:00 - 13:20

    Closing Remarks.

    Rafael Bernabeu. Instituto Bernabeu. Alicante, Spain.